Gene · 7301
Papers2,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| STELLAR-311: a randomized phase II/III study of zanzalintinib versus everolimus in advanced neuroendocrine tumors. | Future Oncol | 2026 | 42803451 | PubTator, text mining | PubMed |
| Aberrant expression of MERTK activates BCR via CD79a in CLL cells: alternative therapeutic strategy for relapsed/refractory CLL. | Leukemia | 2026 | 42778661 | PubTator, text mining | PubMed |
| Sagittal Alignment in Adolescent Idiopathic Scoliosis with Major Thoracic Curves: Pelvic Incidence and Its Influences on Lumbar Lordosis and Thoracic Kyphosis. | Spine (Phila Pa 1976) | 2026 | 42773950 | PubTator, text mining | PubMed |
| Structural organization of TAM receptor ectodomains. | Biochem J | 2026 | 42770830 | PubTator, text mining | PubMed |
| Lactylation-Driven PROS1-TYRO3-CARF Signaling Promotes Therapy-Induced Senescence Escape and Radioresistance in Meningioma. | Adv Sci (Weinh) | 2026 | 42750190 | PubTator, text mining | PubMed |
| Cross-organ crosstalk in brain-aging-related sarcopenia: Caudate iron accumulation impairs muscle health via blood-brain barrier dysfunction. | Brain Res Bull | 2026 | 42748982 | PubTator, text mining | PubMed |
| Expression of TAM receptors and their ligands in unexplained recurrent pregnancy loss. | Immunol Res | 2026 | 42684543 | PubTator, text mining | PubMed |
| Anticancer Effects of Cucurbitacin B and Meleagrin Associated with TYRO3 Downregulation in Colorectal Cancer Cells. | Int J Mol Sci | 2026 | 42589416 | PubTator, text mining | PubMed |
| Anti-inflammatory CAR-microglia targeting Aβ for Alzheimer's disease therapy. | Front Immunol | 2026 | 42523631 | PubTator, text mining | PubMed |
| Receptor-Ligand Biomarker Profile in Ankylosing Spondylitis: Associations Between AXL/MERTK Expression, Circulating GAS6 and Protein S Levels, and Disease Activity. | Life (Basel) | 2026 | 42514136 | PubTator, text mining | PubMed |
| First-Trimester Maternal Serum Growth Arrest-Specific Protein 6 (Gas6) Levels for the Prediction of Preeclampsia. | J Clin Med | 2026 | 42513518 | PubTator, text mining | PubMed |
| Microglia in Alzheimer's Disease: From Homeostatic Guardians to Multifaceted Drivers of Neuropathology. | Cells | 2026 | 42505400 | PubTator, text mining | PubMed |
| Kinase Inhibitor Cardiotoxicity Database (KICDB): a causality-oriented multi-omics database for kinase inhibitor-induced cardiotoxicity. | Br J Pharmacol | 2026 | 42464730 | PubTator, text mining | PubMed |
| Protein S: a vitamin K-dependent factor bridging haemostasis, tissue homeostasis and cancer. | Biochem J | 2026 | 42429079 | PubTator, text mining | PubMed |
| TAM receptor tyrosine kinases as potential mediators of the non-lytic spread of non-enveloped viruses. | Biochem Soc Trans | 2026 | 42101422 | PubTator, text mining | PubMed |
| Novel Efferocytosis-Related Prognostic Signature for Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization. | Gut Liver | 2026 | 42093115 | PubTator, text mining | PubMed |
| TYRO3, AXL, MERTK and Their Ligands in Brain Metastases From Colorectal Cancers. | Cancer Med | 2026 | 42043872 | PubTator, text mining | PubMed |
| Targeting TYRO3 attenuates apoptotic cell-driven cancer stemness in triple negative breast cancer. | Cell Commun Signal | 2026 | 42026668 | PubTator, text mining | PubMed |
| Preclinical evaluation of CPL423: a novel potent small-molecule inhibitor of TAM family and FLT3 kinase for cancer therapy. | Front Pharmacol | 2026 | 41958931 | PubTator, text mining | PubMed |
| Integrative Single-Cell and Machine Learning Analysis Identifies an EMT-Associated Prognostic Signature for Papillary Thyroid Cancer. | Cancer Med | 2026 | 41957879 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7301/papers